WuXi Healthcare Ventures, the venture capital arm of New York Stock Exchange-listed pharmaceutical research and development services provider WuXi PharmaTech, has closed its second venture fund at U$290 million, according to an announcement. The WuXi Healthcare Ventures II, L.P. counts parent WuXi PharmaTech as the anchor investor and sponsor. The new fund exceeded its initial […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.